Cell non-autonomous signaling through the conserved C . elegans glycoprotein hormone receptor FSHR-1 regulates cholinergic neurotransmission
Morgan Buckley,William P. Jacob,Letitia Bortey,Makenzi E. McClain,Alyssa L. Ritter,Amy Godfrey,Allyson S. Munneke,Shankar Ramachandran,Signe Kenis,Julie C. Kolnik,Sarah Olofsson,Milica Nenadovich,Tanner Kutoloski,Lillian Rademacher,Alexandra Alva,Olivia Heinecke,Ryan Adkins,Shums Parkar,Reesha Bhagat,Jaelin Lunato,Isabel Beets,Michael M. Francis,Jennifer R. Kowalski
DOI: https://doi.org/10.1371/journal.pgen.1011461
IF: 4.5
2024-11-24
PLoS Genetics
Abstract:Modulation of neurotransmission is key for organismal responses to varying physiological contexts such as during infection, injury, or other stresses, as well as in learning and memory and for sensory adaptation. Roles for cell autonomous neuromodulatory mechanisms in these processes have been well described. The importance of cell non-autonomous pathways for inter-tissue signaling, such as gut-to-brain or glia-to-neuron, has emerged more recently, but the cellular mechanisms mediating such regulation remain comparatively unexplored. Glycoproteins and their G protein-coupled receptors (GPCRs) are well-established orchestrators of multi-tissue signaling events that govern diverse physiological processes through both cell-autonomous and cell non-autonomous regulation. Here, we show that follicle stimulating hormone receptor, FSHR-1, the sole Caenorhabditis elegans ortholog of mammalian glycoprotein hormone GPCRs, is important for cell non-autonomous modulation of synaptic transmission. Inhibition of fshr-1 expression reduces muscle contraction and leads to synaptic vesicle accumulation in cholinergic motor neurons. The neuromuscular and locomotor defects in fshr-1 loss-of-function mutants are associated with an underlying accumulation of synaptic vesicles, build-up of the synaptic vesicle priming factor UNC-10/RIM, and decreased synaptic vesicle release from cholinergic motor neurons. Restoration of FSHR-1 to the intestine is sufficient to restore neuromuscular activity and synaptic vesicle localization to fshr-1- deficient animals. Intestine-specific knockdown of FSHR-1 reduces neuromuscular function, indicating FSHR-1 is both necessary and sufficient in the intestine for its neuromuscular effects. Re-expression of FSHR-1 in other sites of endogenous expression, including glial cells and neurons, also restored some neuromuscular deficits, indicating potential cross-tissue regulation from these tissues as well. Genetic interaction studies provide evidence that downstream effectors gsa-1 / G α S , acy-1 /adenylyl cyclase and sphk-1/ sphingosine kinase and glycoprotein hormone subunit orthologs, GPLA-1/GPA2 and GPLB-1/GPB5, are important for intestinal FSHR-1 modulation of the NMJ. Together, our results demonstrate that FSHR-1 modulation directs inter-tissue signaling systems, which promote synaptic vesicle release at neuromuscular synapses. Communication to the nervous system from other tissues, such as gut-to-brain signaling, helps to coordinate organismal responses to a variety of stresses, including infection, injury, and aging, as well as for learning, memory, and sensorimotor function. How this inter-tissue regulation of neurons occurs is not fully understood. Here we describe a role for a conserved glycoprotein hormone receptor, FSHR-1, in regulating neuromuscular signaling necessary for motility in C. elegans, a model roundworm that shares high genetic and nervous system conservation with humans. Our results indicate that FSHR-1 can act in the intestine, as well as in several other tissues, to promote signaling from excitatory motor neurons and muscle excitation. We further show FSHR-1 is specifically required in the intestine, where it works in conjunction with two known glycoprotein ligands and several known effector molecules, to regulate neuromuscular function. As related mammalian glycoprotein receptors are implicated in neurological and neurodegenerative conditions, our work is relevant for understanding human nervous system function and the impacts of neurological disease.
genetics & heredity